2024年度欣博盛自產(chǎn)試劑盒獎學(xué)金計劃
使用欣博盛品牌（NeoBioscience）ELISA試劑盒在 SCI 期刊上發(fā)表學(xué)術(shù)文章，
文章中注明試劑盒購自“ NeoBioscience Technology Co. Ltd. ”，
滿足條件，即可申請獎勵！
現(xiàn)獎學(xué)金申請可優(yōu)先通過官網(wǎng)填報（網(wǎng)址：獎學(xué)金申請 - 欣博盛生物 (neobioscience.net)），
但仍可直接通過原本的郵件/業(yè)務(wù)員/經(jīng)銷商等方式聯(lián)系。
使用欣博盛品牌(Neobioscience) ELISA試劑盒在SCI期刊上發(fā)表學(xué)術(shù)文章并注明試劑盒購自“Neobioscience Technology Co,Ltd.”
官網(wǎng)申請：訪問本站點m.haiqingquan.com 在”獎學(xué)金申請”頁面在線提交申請表。
收到您的獎學(xué)金申請后，欣博盛生物將在7個工作日內(nèi)審核并處理。審核通過后，將根據(jù)您文章的影響因子(IF)發(fā)放獎勵。
IF越高，獎勵越多！欣博盛生物祝您多發(fā)Paper多拿獎勵！
● 申請文章需于2024年發(fā)表（以見刊時間為準），文章影響因子（IF）以申請時該期刊的數(shù)據(jù)為準；
● 獲獎老師為文章第一作者或共同第一作者，每篇文章僅能申請一次獎勵；
● 文章內(nèi)使用指標與購買的試劑盒指標須一致；
● 以96T試劑盒為單位計算，申請文章總數(shù)不能多于三年內(nèi)購買試劑盒的總數(shù)；
● 購物金僅限購買欣博盛ELISA時從單筆訂單中抵扣；
● 本活動最終解釋權(quán)歸欣博盛生物所有。
期刊：Translational Oncology, 2023
首都醫(yī)科大學(xué)宣武醫(yī)院-張老師
使用產(chǎn)品：Human IFN-γ and TNF-α ELISA Kit
● 我用過貴公司的多種細胞因子的ELISA檢測試劑盒，包括顆粒酶B和穿孔素等。首先覺得試劑盒的質(zhì)量就很好，每次檢測后標準曲線均一性不錯，數(shù)據(jù)的可重復(fù)性強。其次試劑盒使用方便，簡單，說明書寫得很明確，操作起來可重復(fù)性也很好?？傊?，使用貴公司的ELISA試劑盒體驗極佳，接下來的科研工作如果做到ELISA實驗，也會首選欣博盛的產(chǎn)品。
期刊：Annals of the New York Academy of Sciences, 2023
武漢大學(xué)口腔醫(yī)院-彭老師
使用產(chǎn)品：Mouse IL-1β ELISA Kit
● 非常方便，并且說明書上的步驟也非常詳細，上手很快，反應(yīng)也比較靈敏，副孔之間以及每次重復(fù)的結(jié)果相差都不大，擬合出來的標準曲線R2值比較高，可信度也很不錯。
期刊：Immunity, 2023
南方醫(yī)科大學(xué)-曾老師
使用產(chǎn)品：Mouse TNF-α, IL-1β, IL-6 and IL-18 ELISA Kits
● 我用過好多欣博盛ELISA試劑盒，包括鼠的IL-1β、TNF-α等，總體感覺不錯。比起進口試劑盒，價格要公道便宜的多；與國內(nèi)其他公司相比，應(yīng)該算是國產(chǎn)頂級梯隊的產(chǎn)品了，值得信賴。
● LV J W Y, YIN J H, et al. 2023. The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment. Nature Medicine [J], 6 June 2023. (IF=82.9)
● SHI X, SUN Q, HOU Y, et al. 2023. Recognition and maturation of IL-18 by caspase-4 noncanonical inflammasome. Nature [J], 22 November 2023. (IF=64.8)
● CHEN X W R, LI L, et al. 2023. Pregnancy-induced changes to the gut microbiota drive macrophage pyroptosis and exacerbate septic inflammation. Immunity [J], 14 February 2023. (IF=32.4)
● CHENG J Y J, LIU Y, et al. 2023. Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironment. Cell Metabolism [J], 12 May 2023. (IF=29)
● ZENG Y W R, WANG F, et al. 2023. Liberation of daidzein by gut microbial β-galactosidase suppresses acetaminophen-induced hepatotoxicity in mice. Cell Host & Microbe [J], 25 April 2023. (IF=30.3)
● LIANG W Y Y, GONG S, et al. 2023. Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease. Cell Host & Microbe [J], 15 May 2023. (IF=30.3)
● LIU W Z S, LI Q, et al. 2023. Lactate modulates iron metabolism by binding soluble adenylyl cyclase. Cell Metabolism [J], 21 July 2023. (IF=29)
● WANG J Z L, WU N, et al. 2023. Inhibition of Phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells. Drug Resistance Updates [J], 14 June 2023. (IF=24.3)
● GUO Y Z X N, SU S, et al. 2023. β-adrenoreceptor-triggered PKA activation negatively regulates the innate antiviral response. Cellular & Molecular Immunology [J], 5 January 2023. (IF=24.1)
● SHI Y S J, SUN Y, et al. 2023. A Hierarchical 3D Graft Printed with Nanoink for Functional Craniofacial Bone Restoration. Advanced Functional Materials [J], 6 June 2023. (IF=19)
● LI X L Z, WANG P, et al. 2023. Dopamine‐Integrated Nanointerface between Fibrillar Matrix and Hydrophilic Nanohydroxyapatite Regulates Immune Microenvironment to Boost Endogenous Bone Regeneration. Advanced Functional Materials [J], 17January 2023. (IF=19)
● ZHANG X Y Y, LI J, et al. 2023. Engineered Oxygen Factories Synergize with STING Agonist to Remodel Tumor Microenvironment for Cancer Immunotherapy. Advanced Functional Materials [J], 19 June 2023. (IF=19)
● ZHANG L H S, MOVAHEDI F, ET AL. 2023. Amyloid-β/Tau burden and neuroinflammation dual-targeted nanomedicines synergistically restore memory and recognition of Alzheimer’s disease mice. Nano Today [J], 20 February 2023. (IF=17.4)
● SHI X, SUN Q, HOU Y, et al. 2023. Recognition and maturation of IL-18 by caspase-4 noncanonical inflammasome. Nature [J], 624: 442-450.
● ZHOU P, SHE Y, DONG N, et al. 2018. Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose. Nature [J], 561: 122-126.
● SHI J, ZHAO Y, WANG K, et al. 2015. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature [J], 526: 660-665.
● XU H, YANG J, GAO W, et al. 2014. Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature [J], 513: 237-241.
● ZHAO Y, YANG J, SHI J, et al. 2011. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature [J], 477: 596-600.
